Great Southern Copper, Sunda Energy, Faron Pharmaceuticals, Astrid Intelligence, Bellevue Healthcare

Group 1 - Great Southern Copper PLC has reported significant drilling results in Chile, with a step-out hole returning up to 6.55% copper and 320 grams per tonne silver, indicating that the Mostaza Fault Zone is larger than previously estimated [1] - Sunda Energy PLC has successfully cleared a crucial environmental hurdle for its Chuditch-2 well offshore Timor-Leste, with the license valid until 2028, allowing the company to proceed with drilling [1] Group 2 - Faron Pharmaceuticals Limited is raising €40 million to fund a trial for its blood cancer drug bexmarilimab, which will cover a 90-patient study and extend the company's financial runway to November 2027 [2] - Astrid Intelligence PLC has acquired a validator on the Bittensor network, enhancing its active participation and shifting its focus from merely holding tokens to operating infrastructure [2] Group 3 - Bellevue Healthcare Trust PLC has sold 13.1 million treasury shares to Threadneedle at a price of 142.57p each, raising nearly £19 million, which the board deems fair to shareholders [3]